Skip to main content

Find Clinical Trials

Home
Conditions
Pheochromocytoma/Paraganglioma (PPGL)

Clinical trial condition

Pheochromocytoma/Paraganglioma (PPGL)

Explore clinical trials studying Pheochromocytoma/Paraganglioma (PPGL). Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Pheochromocytoma/Paraganglioma (PPGL) trial results

Recruiting

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

NCT06503146

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +57 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma

NCT07288931

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +6 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Enrolling by Invitation

Comparative Study of Perioperative Cardiac Injury in Patients With Functional Adrenal Tumors

NCT07182175

Conditions: Adrenal Gland Diseases, Adrenal Gland Neoplasms, Adrenal Tumor, +16 more
Locations: Peking University First Hospital Beijing, China

View Trial Details